These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 1348238)

  • 1. Quality of life of schizophrenic patients on medications and implications for new drug trials.
    Awad AG
    Hosp Community Psychiatry; 1992 Mar; 43(3):262-5. PubMed ID: 1348238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A conceptual model of quality of life in schizophrenia: description and preliminary clinical validation.
    Awad AG; Voruganti LN; Heslegrave RJ
    Qual Life Res; 1997 Jan; 6(1):21-6. PubMed ID: 9062438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subjective response to neuroleptics and the quality of life: implications for treatment outcome.
    Awad AG; Hogan TP
    Acta Psychiatr Scand Suppl; 1994; 380():27-32. PubMed ID: 7914044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of therapeutic response in schizophrenia. A critical survey.
    Collins EJ; Hogan TP; Desai H
    Schizophr Res; 1991 Oct; 5(3):249-53. PubMed ID: 1684722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of life in schizophrenic patients.
    Bobes J; Garcia-Portilla MP; Bascaran MT; Saiz PA; Bousoño M
    Dialogues Clin Neurosci; 2007; 9(2):215-26. PubMed ID: 17726919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of life in schizophrenia: insight and subjective response to neuroleptics.
    Browne S; Garavan J; Gervin M; Roe M; Larkin C; O'Callaghan E
    J Nerv Ment Dis; 1998 Feb; 186(2):74-8. PubMed ID: 9484306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fewer symptoms vs. more side-effects in schizophrenia? Opposing pathways between antipsychotic medication compliance and quality of life.
    Staring AB; Mulder CL; Duivenvoorden HJ; De Haan L; Van der Gaag M
    Schizophr Res; 2009 Aug; 113(1):27-33. PubMed ID: 19525092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting neuroleptic response from a combination of multilevel variables in acute schizophrenic patients.
    Bartkó G; Frecska E; Horváth S; Zádor G; Arató M
    Acta Psychiatr Scand; 1990 Dec; 82(6):408-12. PubMed ID: 1981296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Domain-specific subjective quality of life and illness-related limitations of chronic schizophrenic patients].
    Lauer G; Stegmüller-Koenemund U
    Psychiatr Prax; 1994 Mar; 21(2):70-3. PubMed ID: 7910973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects and side effects of antipsychotic treatment in schizophrenia: pros and cons of available self-rating scales.
    Wolters HA; Knegtering H; van den Bosch RJ; Wiersma D
    Schizophr Res; 2009 Jul; 112(1-3):114-8. PubMed ID: 19395241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implications for the pharmacotherapy of schizophrenia.
    Rep Group Adv Psychiatry; 1992; (134):35-58. PubMed ID: 1348372
    [No Abstract]   [Full Text] [Related]  

  • 12. Drugs and the quality of life: the patient's point of view.
    Diamond R
    J Clin Psychiatry; 1985 May; 46(5 Pt 2):29-35. PubMed ID: 2859278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Subjective well-being under antipsychotic treatment and its meaning for compliance and course of disease].
    Naber D; Lambert M; Karow A
    Psychiatr Prax; 2004 Nov; 31 Suppl 2():S230-2. PubMed ID: 15586315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subjective utility ratings of neuroleptics in treating schizophrenia.
    Finn SE; Bailey JM; Schultz RT; Faber R
    Psychol Med; 1990 Nov; 20(4):843-8. PubMed ID: 1980954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Quality of life in patients with schizophrenia: a study of 100 cases].
    Zouari L; Thabet JB; Elloumi Z; Elleuch M; Zouari N; Maâlej M
    Encephale; 2012 Apr; 38(2):111-7. PubMed ID: 22516268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do neuroleptics cause depression?
    Roy A
    Biol Psychiatry; 1984 May; 19(5):777-81. PubMed ID: 6145454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New antipsychotic medications: do research results relate to clinical practice?
    MacEwan GW
    Can J Psychiatry; 1993 Sep; 38 Suppl 3():S75-9. PubMed ID: 7504572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Quality of life of schizophrenic patients and clozapine].
    Raoul Y; Manesse P; Delage M
    Encephale; 1997 Sep; 23 Spec No 4():12-6. PubMed ID: 9417398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The (new) definition of compliance].
    Arolt V
    Krankenpfl J; 2005; 43(7-10):214-5. PubMed ID: 16515287
    [No Abstract]   [Full Text] [Related]  

  • 20. Assessment of the patient's subjective experience in acute neuroleptic treatment: implications for compliance and outcome.
    Awad AG; Voruganti LN; Heslegrave RJ; Hogan TP
    Int Clin Psychopharmacol; 1996 May; 11 Suppl 2():55-9. PubMed ID: 8803661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.